Delivers ~13% Net Sales Growth
Company Updates 2026 Outlook; Raises Net Sales Guidance
First Quarter 2026 Financial Highlights Compared to Prior Year Period
- Net sales of
$297.6 million , an increase of 13.1%. - Gross margin of 40.5%, compared to the prior year period of 39.4%.
- Adjusted Gross Margin of 46.9%, compared to the prior year period of 45.7%.1
- Net income of
$48.5 million , compared to the prior year period net loss of$12.7 million . - Adjusted EBITDA of
$37.9 million , compared to the prior year period of$35.5 million .1
"We are encouraged by our strong start to 2026, delivering first quarter sales growth in excess of our 2026 guidance and reinforcing our confidence in
First Quarter 2026
Net sales increased 13.1% to
Gross profit was
Selling, general and administrative expenses (“SG&A”) were
Net income was
Adjusted EBITDA was
Balance Sheet
As of
The Company will utilize its balance sheet to support its ongoing capital needs in connection with its long-term capacity plan.
Outlook
For full year 2026, the Company is updating its guidance and now expects the following:
- Net sales growth in the range of 8% to 11%, compared to an increase of 7% to 10% in the previous guidance;
- Adjusted EBITDA in the range of
$205 million to$215 million , unchanged from the previous guidance; and - Positive free cash flow with capital expenditures of
~$150 million , unchanged from the previous guidance.
The Company does not provide guidance for net income, the
Conference Call & Earnings Presentation Webcast Information
As previously announced, today,
About
Forward Looking Statements
Certain statements in this press release constitute “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995 and are based on our current expectations and assumptions. These include statements regarding our confidence in
Non-GAAP Financial Measures
- Adjusted Gross Profit
- Adjusted Gross Profit as a percentage of net sales (Adjusted Gross Margin)
- Adjusted SG&A Expenses
- Adjusted SG&A Expenses as a percentage of net sales
- EBITDA
- Adjusted EBITDA
- Adjusted EBITDA as a percentage of net sales (Adjusted EBITDA Margin)
- Free Cash Flow
Adjusted Gross Profit:
Adjusted SG&A Expenses:
EBITDA and Adjusted EBITDA: EBITDA represents net income (loss) plus depreciation and amortization expense, interest expense net of interest income and income tax expense, and Adjusted EBITDA represents EBITDA less gain on equity investment, plus non-cash share-based compensation expense, loss on disposal of property, plant and equipment, distributor transition costs, legal obligation, and international business charges.
Free Cash Flow:
Management believes that the non-GAAP financial measures are meaningful to investors because they provide a view of the Company with respect to ongoing operating results. The non-GAAP financial measures are shown as supplemental disclosures in this release because they are widely used by the investment community for analysis and comparative evaluation. They also provide additional metrics to evaluate the Company’s operations and, when considered with both the Company’s GAAP results and the reconciliation to their most directly comparable
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited, in thousands, except per share data) | |||||||
2026 | 2025 | ||||||
| ASSETS | |||||||
| CURRENT ASSETS: | |||||||
| Cash and cash equivalents | $ | 381,381 | $ | 277,975 | |||
| Accounts receivable, net of allowance for doubtful accounts | 65,370 | 63,762 | |||||
| Inventories, net | 80,588 | 76,766 | |||||
| Prepaid expenses | 7,338 | 9,807 | |||||
| Other current assets | 7,115 | 7,404 | |||||
| Total Current Assets | 541,792 | 435,714 | |||||
| Property, plant and equipment, net | 1,143,589 | 1,138,671 | |||||
| Operating lease right of use assets | 65,596 | 66,424 | |||||
| Long term investment in equity securities | — | 33,446 | |||||
| Deferred tax assets, net | 52,824 | 68,893 | |||||
| Other assets | 35,378 | 34,627 | |||||
| Total Assets | $ | 1,839,179 | $ | 1,777,775 | |||
| LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||
| CURRENT LIABILITIES: | |||||||
| Accounts payable | $ | 35,463 | $ | 42,429 | |||
| Accrued expenses | 47,504 | 31,610 | |||||
| Current operating lease liabilities | 2,336 | 2,241 | |||||
| Current finance lease liabilities | 2,346 | 2,315 | |||||
| Total Current Liabilities | $ | 87,649 | $ | 78,595 | |||
| Convertible senior notes | 397,884 | 397,330 | |||||
| Long term operating lease liabilities | 64,412 | 65,023 | |||||
| Long term finance lease liabilities | 27,060 | 28,075 | |||||
| Deferred tax liabilities, net | 111 | 93 | |||||
| Total Liabilities | $ | 577,116 | $ | 569,116 | |||
| Commitments and contingencies | — | — | |||||
| STOCKHOLDERS' EQUITY: | |||||||
| Common stock — voting, | 49 | 49 | |||||
| Additional paid-in capital | 1,356,890 | 1,351,201 | |||||
| Accumulated deficit | (94,161 | ) | (142,669 | ) | |||
| Accumulated other comprehensive (loss) income | (459 | ) | 334 | ||||
| (256 | ) | (256 | ) | ||||
| Total Stockholders' Equity | 1,262,063 | 1,208,659 | |||||
| Total Liabilities and Stockholders' Equity | $ | 1,839,179 | $ | 1,777,775 | |||
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS) AND COMPREHENSIVE INCOME (LOSS) (Unaudited, in thousands, except per share data) | |||||||
| For the Three Months Ended | |||||||
| 2026 | 2025 | ||||||
| $ | 297,644 | $ | 263,249 | ||||
| COST OF GOODS SOLD | 176,970 | 159,461 | |||||
| GROSS PROFIT | 120,674 | 103,788 | |||||
| SELLING, GENERAL, AND ADMINISTRATIVE EXPENSES | 116,343 | 115,285 | |||||
| INCOME (LOSS) FROM OPERATIONS | 4,331 | (11,497 | ) | ||||
| OTHER INCOME (EXPENSES): | |||||||
| Interest and Other Income, net | 2,883 | 2,393 | |||||
| Interest Expense | (3,586 | ) | (3,459 | ) | |||
| Gain on | 62,013 | — | |||||
| TOTAL OTHER INCOME (EXPENSES) | 61,310 | (1,066 | ) | ||||
| INCOME (LOSS) BEFORE INCOME TAXES | 65,641 | (12,563 | ) | ||||
| INCOME TAX EXPENSE | 17,133 | 134 | |||||
| INCOME (LOSS) ATTRIBUTABLE TO COMMON STOCKHOLDERS | $ | 48,508 | $ | (12,697 | ) | ||
| OTHER COMPREHENSIVE (LOSS) INCOME: | |||||||
| Change in foreign currency translation | $ | (793 | ) | $ | 211 | ||
| TOTAL OTHER COMPREHENSIVE (LOSS) INCOME | (793 | ) | 211 | ||||
| TOTAL COMPREHENSIVE INCOME (LOSS) | $ | 47,715 | $ | (12,486 | ) | ||
| NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS | |||||||
| -BASIC | $ | 0.99 | $ | (0.26 | ) | ||
| -DILUTED | $ | 0.91 | $ | (0.26 | ) | ||
| WEIGHTED AVERAGE SHARES OF COMMON STOCK OUTSTANDING | |||||||
| -BASIC | 49,062 | 48,733 | |||||
| -DILUTED | 56,060 | 48,733 | |||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited, in thousands) | |||||||
| For the Three Months Ended | |||||||
| 2026 | 2025 | ||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||
| Net income (loss) | $ | 48,508 | $ | (12,697 | ) | ||
| Adjustments to reconcile net income (loss) to net cash flows provided by operating activities: | |||||||
| Provision for loss on accounts receivable | — | 11,452 | |||||
| Loss on disposal of property, plant and equipment | 126 | 744 | |||||
| Share-based compensation | 9,137 | 8,816 | |||||
| Depreciation and amortization | 24,990 | 21,827 | |||||
| Amortization of deferred financing costs | 554 | 535 | |||||
| Change in operating lease right of use asset | 828 | 309 | |||||
| Deferred income taxes | 16,089 | — | |||||
| Gain on equity investment | (62,013 | ) | — | ||||
| Changes in operating assets and liabilities: | |||||||
| Accounts receivable | (1,407 | ) | (5,609 | ) | |||
| Inventories | (3,149 | ) | (2,952 | ) | |||
| Prepaid expenses and other current assets | 544 | 688 | |||||
| Other assets | (1,334 | ) | (1,102 | ) | |||
| Accounts payable | (8,128 | ) | 4,574 | ||||
| Accrued expenses | 16,100 | (21,461 | ) | ||||
| Operating lease liability | (516 | ) | (317 | ) | |||
| Net cash flows provided by operating activities | 40,329 | 4,807 | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||||
| Proceeds from sale of equity investment | 95,459 | — | |||||
| Acquisitions of property, plant and equipment, software and deposits on equipment | (27,599 | ) | (26,491 | ) | |||
| Net cash flows provided by (used in) investing activities | 67,860 | (26,491 | ) | ||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||||
| Proceeds from exercise of options to purchase common stock | 743 | 157 | |||||
| Tax withholdings related to net shares settlements of restricted stock units | (4,542 | ) | (2,861 | ) | |||
| Principal payments under finance lease obligations | (984 | ) | (513 | ) | |||
| Net cash flows used in financing activities | (4,783 | ) | (3,217 | ) | |||
| NET CHANGE IN CASH AND CASH EQUIVALENTS | 103,406 | (24,901 | ) | ||||
| CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR | 277,975 | 268,633 | |||||
| CASH AND CASH EQUIVALENTS, END OF PERIOD | $ | 381,381 | $ | 243,732 | |||
RECONCILIATION BETWEEN GROSS PROFIT AND ADJUSTED GROSS PROFIT | |||||||
| Three Months Ended | |||||||
| 2026 | 2025 | ||||||
| (Dollars in thousands) | |||||||
| Gross profit | $ | 120,674 | $ | 103,788 | |||
| Depreciation expense | 17,298 | 15,179 | |||||
| Non-cash share-based compensation | 1,588 | 1,283 | |||||
| Loss (gain) on disposal of manufacturing equipment | 12 | (5 | ) | ||||
| Adjusted Gross Profit | $ | 139,572 | $ | 120,245 | |||
| Adjusted Gross Profit as a % of | 46.9 | % | 45.7 | % | |||
RECONCILIATION BETWEEN SG&A EXPENSES AND ADJUSTED SG&A EXPENSES | |||||||
| Three Months Ended | |||||||
| 2026 | 2025 | ||||||
| (Dollars in thousands) | |||||||
| SG&A expenses | $ | 116,343 | $ | 115,285 | |||
| Depreciation and amortization expense | 6,980 | 5,937 | |||||
| Non-cash share-based compensation (a) | 7,549 | 7,533 | |||||
| Loss on disposal of equipment | 114 | 166 | |||||
| Distributor transition costs (b) | — | 10,680 | |||||
| Legal obligation (c) | — | 4,987 | |||||
| International business charges (d) | — | 1,273 | |||||
| Adjusted SG&A Expenses | $ | 101,700 | $ | 84,709 | |||
| Adjusted SG&A Expenses as a % of | 34.2 | % | 32.2 | % | |||
| (a) | Includes true-ups to share-based compensation expense. We have certain outstanding share-based awards with performance-based vesting conditions that require the achievement of certain Adjusted EBITDA margins, Adjusted EBITDA and/or |
| (b) | Represents a non-recurring loss as a result of an accounts receivable write-off in connection with the liquidation of one of our pet specialty distributors. Concurrent with its liquidation, we transitioned to a new distribution partner, who is a leading pet specialty distributor and who we anticipate will facilitate sales to pet specialty stores. Thus, despite the transitory impact during the first quarter of 2025, our ability to continue to generate sales is consistent with what we would expect to generate within the pet specialty channel. |
| (c) | Represents the net settlement charges for all claims related to the litigation with Phillips. |
| (d) | Represents termination costs due to a business change in our international go-to-market strategy. |
RECONCILIATION BETWEEN | |||||||
| Three Months Ended | |||||||
| 2026 | 2025 | ||||||
| (Dollars in thousands) | |||||||
| Net income (loss) | $ | 48,508 | $ | (12,697 | ) | ||
| Depreciation and amortization | 24,278 | 21,116 | |||||
| Interest expense, net of interest income | 705 | 1,064 | |||||
| Income tax expense | 17,133 | 134 | |||||
| EBITDA | 90,624 | 9,617 | |||||
| Non-cash share-based compensation (a) | 9,137 | 8,816 | |||||
| Loss on disposal of property, plant and equipment | 126 | 161 | |||||
| Gain on equity investment | (62,013 | ) | — | ||||
| Distributor transition costs (b) | — | 10,680 | |||||
| Legal obligation (c) | — | 4,987 | |||||
| International business charges (d) | — | 1,273 | |||||
| Adjusted EBITDA | $ | 37,874 | $ | 35,534 | |||
| Adjusted EBITDA as a % of | 12.7 | % | 13.5 | % | |||
| (a) | Includes true-ups to share-based compensation expense. We have certain outstanding share-based awards with performance-based vesting conditions that require the achievement of certain Adjusted EBITDA margins, Adjusted EBITDA and/or |
| (b) | Represents a non-recurring loss as a result of an accounts receivable write-off in connection with the liquidation of one of our pet specialty distributors. Concurrent with its liquidation, we transitioned to a new distribution partner, who is a leading pet specialty distributor and who we anticipate will facilitate sales to pet specialty stores. Thus, despite the transitory impact during the first quarter of 2025, our ability to continue to generate sales is consistent with what we would expect to generate within the pet specialty channel. |
| (c) | Represents the net settlement charges for all claims related to the litigation with Phillips. |
| (d) | Represents termination costs due to a business change in our international go-to-market strategy. |
RECONCILIATION BETWEEN NET CASH FLOWS PROVIDED BY OPERATING ACTIVITIES AND FREE CASH FLOW | |||||||
| Three Months Ended | |||||||
| 2026 | 2025 | ||||||
| (Dollars in thousands) | |||||||
| Net cash flows provided by operating activities | $ | 40,329 | $ | 4,807 | |||
| less: capital expenditures2 | (27,599 | ) | (26,491 | ) | |||
| Free Cash Flow | $ | 12,730 | $ | (21,684 | ) | ||
1 Adjusted Gross Margin, Adjusted Gross Profit, Adjusted SG&A, Adjusted EBITDA and Free Cash Flow are non-GAAP financial measures. See "Non-GAAP Measures" for how the Company defines these measures and the financial tables that accompany this release for reconciliations of these measures to the closest comparable GAAP measures.
2 Capital expenditures is equivalent to the amount included in "Acquisitions of property, plant and equipment, software and deposits on equipment" on our Consolidated Statements of Cash Flows for the reported period.

Investor Contact:Source:Rachel Ulsh Rulsh@freshpet.comMedia Contact:Press@freshpet.com
